How body burden from exposure to endocrine disruptors effects accelerated aging?

Abstract

This paper reviewed various studies on the effects of endocrine disruptors on human health, focusing on accelerated aging in the younger generation. In particular, we analyzed how the modern lifestyle and ignorance of endocrine disruptors in the younger generation are accelerating aging, and how the concentration of endocrine disruptor exposure in the human body affects the body's burden. Based on existing papers, we conducted a systematic review using Web of Science, Google Scholar, and Scopus to comprehensively investigate and summarize the definition of endocrine disruptors, their effects on hormones, and the physical burden of continuous exposure to endocrine disruptors. Research has shown that persistent exposure to endocrine disruptors disrupts homeostasis in the body and creates oxidative stress that can lead to aging and chronic inflammation. These characteristics were also found to be significant in the observation of telomere length, which is a measure of aging. Therefore, in order to prevent accelerated aging in the younger generation, we can suggest ways to minimize exposure to endocrine disruptors and slow down normal aging in the entire public health, including the 3040s, in the long term.

Keywords

• Endocrine disruptors
• chronic disease
• aging
• accelerated aging
• body burden

References

1. V. Bollati, and A. Baccarelli, "Environmental epigenetics," Heredity (Edinb), Vol. 105(1), pp. 105-112, 2010. [CrossRef]
2. R. L. Wong, and C. L. Walker, "Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome," Clinical Cancer Research, Vol. 19(14), pp. 3732-3737, 2013. [CrossRef]
3. T. T. Schug, A. Janesick, B. Blumberg, and J. J. Heindel, "Endocrine disrupting chemicals and disease susceptibility," The Journal of Steroid Biochemistry and Molecular Biology, Vol. 127(3-5), pp. 204-215, 2011. [CrossRef]
4. S. De Coster, and N. van Larebeke, "Endocrine-disrupting chemicals: associated disorders and mechanisms of action," Journal of Environmental and Public Health, Vol. 2012, Article 713696, 2012. [CrossRef]
5. R. T. Zoeller, T. R. Brown, L. L. Doan, A. C. Gore, N. E. Skakkebaek, A. M. Soto, T. J. Woodruff, and F. S. Vom Saal, "Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society," Endocrinology, Vol. 153(9), pp. 4097-4110, 2012. [CrossRef]
6. S. W. Santosh, "Chapter 3.1.2 - Focus on reproductive health and alterations in women," in Environmental Contaminants and Endocrine Health, 179-200, 2023. [CrossRef]
7. A. Vaiserman, "Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: An epigenetic bridge?," Aging and Disease, Vol. 5(6), pp. 419-429, 2014.
8. M. B. Macon, and S. E. Fenton, "Endocrine disruptors and the breast: early life effects and later life disease," Journal of Mammary Gland Biology and Neoplasia, Vol. 18(1), pp. 43-61, 2013. [CrossRef]

9. A. J. Bernal, and R. L. Jirtle, "Epigenomic disruption: the effects of early developmental exposures," Birth Defects Research Part A: Clinical and Molecular Teratology, Vol. 88(10), pp. 938-944, 2010. [CrossRef]
10. M. Kundakovic, and F. A. Champagne, "Epigenetic perspective on the developmental effects of bisphenol A," Brain, Behavior, and Immunity, Vol. 25(6), pp. 1084-1093, 2011. [CrossRef]
11. A. Soundararajan, P. Prabu, V. Mohan, Y. Gibert, and M. Balasubramanyam. "Novel insights of elevated systemic levels of bisphenol-A (BPA) linked to poor glycemic control, accelerated cellular senescence and insulin resistance in patients with type 2 diabetes," Molecular and Cellular Biochemistry, Vol. 458(1-2), pp. 171-183, 2019. [CrossRef]
12. P. D. Darbre, "Endocrine disruptors and obesity," Current Obesity Reports, Vol. 6(1), pp. 18-27, 2017. [CrossRef]
13. P. Arslan, S. C. Özeren, and B. Yurdakök Dikmen, "The effects of endocrine disruptors on fish," Environmental Research and Technology, Vol. 4(2), pp. 145-151, 2021. [CrossRef]
14. O. Kuzukiran, A. Filazi, P. Arslan, B. Yurdakök Dikmen, and U. N. Yazgan Tavşanoğlu, "Determination of persistent organic pollutants in water and sediment samples from Kızılırmak River," Kocatepe Veterinary Journal, Vol. 12(4), pp. 430-436, 2019. [CrossRef]
15. Z.-R. Tang, X.-L. Xu, S.-. Deng, Z.-X. Lian, and K. Yu, "Oestrogenic endocrine disruptors in the placenta and the fetus," International Journal of Molecular Sciences, Vol. 21(4), Article 1519, 2020. [CrossRef]
16. P. D. Darbre, “Endocrine disruption and human health,” Academic Press, pp. 390, 2015.
17. S. Basak, M. K. Das, and A. K. Duttaroy, "Plastics derived endocrine-disrupting compounds and their effects on early development," Birth Defects Research, Vol. 112(17), pp. 1308-1325, 2020. [CrossRef]
18. B. S. Rubin, "Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects," The Journal of Steroid Biochemistry and Molecular Biology, Vol. 127(1-2), pp. 27-34, 2011. [CrossRef]
19. P. Awasthi, and A. Dobhal, "Endocrine disruptors in food contact materials: A health threat," in Food Marketing Technology, 2021.
20. P.-C. Huang, S.-H. Liou, I.-K. Ho, H.-C. Chiang, H.-I. Huang, S.-L. Wang, "Phthalates exposure and endocrinal effects: An epidemiological review," Journal of Food and Drug Analysis, Vol. 20(4), pp. 719-733, 2012.
21. L. Bramwell, S. V. Glinianaia, J. Rankin, M. Rose, A. Fernandes, S. Harrad, T. Pless-Mulolli, "Associations between human exposure to polybrominated diphenyl ether flame retardants via diet and indoor dust, and internal dose: A systematic review," Environment International, Vol. 92-93, pp. 680-694, 2016. [CrossRef]
22. X. Zhao, X. Yang, Y. Du, R. Li, T. Zhou, Y. Wang, T. Chen, D. Wang, Z. Shi," Polybrominated diphenyl ethers in serum from residents living in a brominated flame retardant production area: Occurrence, influencing factors, and relationships with thyroid and liver function," Environmental Pollution, Vol. 270, Article 116046, 2021. [CrossRef]
23. F. T. Celino-Brady, C. K. Petro-Sakuma, J. P. Breves, D. T. Lerner, and A. P. Seale, "Early-life exposure to 17β-estradiol and 4-nonylphenol impacts the growth hormone/insulin-like growth-factor system and estrogen receptors in Mozambique tilapia, Oreochromis mossambicus," Aquatic Toxicology, Vol. 217, Article 105336, 2019. [CrossRef]
24. P. D. Darbre, and P. W. Harvey, "Parabens can enable hallmarks and characteristics of cancer in human breast epithelial cells: a review of the literature with reference to new exposure data and regulatory status," Journal of Applied Toxicology, Vol. 34(9), pp. 925-938, 2014. [CrossRef]
25. C. Bereketoglu, and A. Pradhan, "Plasticizers: negative impacts on the thyroid hormone system," Environmental Science and Pollution Research, Vol. 29, pp. 38912-38927, 2022. [CrossRef]
26. C. H. Kuo, S. N. Yang, P.-L. Kuo, C.-H. Hung, "Immunomodulatory effects of environmental endocrine disrupting chemicals," The Kaohsiung Journal of Medical Sciences, Vol. 28(Suppl 7), pp. S37-S42, 2012. [CrossRef]
27. M. Larsson, L. Hagerhed-Engman, B. Kolarik, P. James, F. C. Lundin, S. Janson, J. Sundell, C. G. Bornehag, "PVC-as flooring material-and its association with incident asthma in a Swedish child cohort study," Indoor Air, Vol. 20(6), pp. 494-501, 2010. [CrossRef]
28. M.B. Zerdan, S. Moussa, A. Atoui, H. I. Assi, "Mechanisms of Immunotoxicity: Stressors and Evaluators," International Journal of Molecular Sciences, Vol. 22(15), Article 8242, 2021. [CrossRef]
29. R. R. Dietert, "Misregulated inflammation as an outcome of early-life exposure to endocrine-disrupting chemicals," Reviews on Environmental Health, Vol. 27(2-3), pp. 117-131, 2012. [CrossRef]
30. C. Monneret, "What is an endocrine disruptor?," Comptes Rendus Biologies, Vol. 340(9-10), pp. 403-405, 2017. [CrossRef]
31. Y. Combarnous, and T. M. D. Nguyen, "Comparative overview of the mechanisms of action of hormones and endocrine disruptor compounds," Toxics, Vol. 7(1), Article 5, 2019. [CrossRef]
32. I.A. Sheikh, R.F. Turki, A. M. Abuzenadah, G. A. Damanhouri, M. A. Beg "Endocrine disruption: computational perspectives on human sex hormone-binding globulin and phthalate plasticizers," PLoS One, vol. 11(3), Article e0151444, 2016. [CrossRef]
33. H. Hong, W.S. Branham, H. W. Ng, C. L. Moland, S. L. Dial, H. Fang, R. Perkins, D. Sheehan, and W. Tong, "Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and alpha-fetoprotein," Toxicological Sciences, Vol. 143(2), pp. 333-348, 2015. [CrossRef]
34. Y. E. Yegorov, A. V. Poznyak, N. G. Nikiforov, I. A. Sobenin, and A. N. Orekhov, "The link between chronic stress and accelerated aging," Biomedicines, Vol. 8(7), Article 198, 2020. [CrossRef]
35. S. Salim, "Oxidative stress: a potential link between emotional wellbeing and immune response," Current Opinion in Pharmacology, Vol. 29, pp. 70-76, 2016. [CrossRef]
36. M. El Assar, J. Angulo, J. A. Carnicero, S. Walter, F. J. García García, E. López-Hernández, J. M. Sánchez‐Puelles, "Frailty is associated with lower expression of genes involved in cellular response to stress: Results from the toledo study for healthy aging," Journal of the American Medical Directors Association, Vol. 18(8), pp. 734-737, 2017. [CrossRef]
37. J. D. Erusalimsky, "Oxidative stress, telomeres and cellular senescence: What non-drug interventions might break the link?," Free Radical Biology and Medicine, Vol. 150, pp. 87-95, 2020. [CrossRef]
38. R. Rampersaud, G. W. Y. Wu, V. I. Reus, J. Lin, E. H. Blackburn, E. S. Epel, C. M. Hough, S. H. Mellon, and O. M. Wolkowitz, "Shorter telomere length predicts poor antidepressant response and poorer cardiometabolic indices in major depression," Scientific Reports, Vol. 13, Article 10238, 2023. [CrossRef]
39. T. Fülöp, A. Larbi, and J. M. Witkowski, "Human inflammaging," Gerontology, Vol. 65(5), pp. 495-504, 2019. [CrossRef]
40. J. J. Goronzy, and C. M. Weyand, "Successful and maladaptive T cell aging," Immunity, Vol. 46(3), pp. 364-378, 2017. [CrossRef]
41. M. Kumar, D. K. Sarma, S. Shubham, M. Kumawat, V. Verma, A. Prakash, and R. Tiwari, "Environmental endocrine-disrupting chemical exposure: role in non-communicable diseases," Public Health, Vol. 8, Article 553850, 2020. [CrossRef]
42. J. Park, H. Lee, and S. Lee., "Interventions on reducing exposure to endocrine disrupting chemicals in human health care context: A scoping review," Risk Management and Healthcare Policy, Vol. 15, pp. 779-791, 2022. [CrossRef]
43. G. Delbes, M. Blázquez, J. I. Fernandino, P. Grigorova, B. F. Hales, C. Metcalfe, L. Navarro-Martín, L. Parent, B. Robaire, A. Rwigemera, G. Van Der Kraak, M. Wade, and V. Marlatt, "Effects of endocrine disrupting chemicals on gonad development: Mechanistic insights from fish and mammals," Environmental Research, Vol. 204, Article 112040, 2022. [CrossRef]
44. A. Guart, F. Bono-Blay, A. Borrell, and S. LAcorte,"Migration of plasticizersphthalates, bisphenol A and alkylphenols from plastic containers and evaluation of risk," Food Additives & Contaminants: Part A, Vol. 28(5), pp. 676-685, 2011. [CrossRef]
45. M. Kelly, L. Connolly, and M. Dean, "Public awareness and risk perceptions of endocrine disrupting chemicals: A qualitative study," International Journal of Environmental Research and Public Health, Vol. 17(21), Article 7778, 2020. [CrossRef]
46. L. Martin, Y. Zhang, O. First, V. Mustieles, R. Dodson, G. Rosa, A. Coburn-Sanderson, C. D. Adams, & C. Messerlian, "Lifestyle interventions to reduce endocrine-disrupting phthalate and phenol exposures among reproductive age men and women: A review and future steps," Environment International, Vol. 170, Article 107576, 2022. [CrossRef]
47. A. Szybiak, A. Rutkowska, K. Wilczewska, A. Wasik, J. Namieśnik, and D. Rachoń, "Daily diet containing canned products significantly increases serum concentrations of endocrine disruptor bisphenol A in young women Polish Archives of Internal Medicine, Vol. 127(4), pp. 278-280, 2017. [CrossRef]
48. J. L. Carwile, X. Ye, Zhou X, A. M. Calafat, K. B. Michels, "Canned soup consumption and urinary bisphenol A: a randomized crossover trial," JAMA, Vol. 306(20), pp. 2218-2220, 2011. [CrossRef]
49. R. A. Rudel, J. M. Gray, C. L. Engel, T. W. Rawsthorne, R. E. Dodson, J. M. Ackerman, J. Rizzo, J. L. Nudelman, and J. G. Brody, "Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention," Environmental Health Perspectives, Vol. 119(7), pp. 914-920, 2011. [CrossRef]
50. T. Hagobian, A. Smouse, M. Streeter, C. Wurst, A. Schaffner, and S. Phelan., "Randomized intervention trial to decrease bisphenol a urine concentrations in women: Pilot study," Journal of Women's Health, Vol. 26(2), pp. 128-132, 2017. [CrossRef]